Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v2-FR
Language French French
Date Updated 2017-12-15 2017-07-05
Drug Identification Number 02391090 02391090
Brand name LABETALOL HYDROCHLORIDE INJECTION USP LABETALOL HYDROCHLORIDE INJECTION USP
Common or Proper name LABETALOL HYDROCHLORIDE LABETALOL HYDROCHLORIDE
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients LABETALOL HYDROCHLORIDE LABETALOL HYDROCHLORIDE
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1X20ML 1X20ML
ATC code C07AG C07AG
ATC description BETA BLOCKING AGENTS BETA BLOCKING AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2017-09-01
Actual start date 2017-10-05
Estimated end date Unknown Unknown
Actual end date 2017-11-13
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.
Health Canada comments